+ A
A -
Tribune News Network
Doha
TREATMENT of childhood cancer has been dramatically improved by advances in drug therapies over the years, an expert on paediatric oncology has said. He was explaining developments in childhood cancer care over the past several decades at Weill Cornell Medicine-Qatar’s (WCM-Q) Grand Rounds.
Dr Roger L Berkow, professor and vice chair of Pediatrics at the University of South Alabama (USA), also discussed the challenges to further progress.
Dr Berkow, who gave the lecture during a visit to WCM-Q as part of the college’s Visiting Professorship Program (VPP), said: “The cure rate over the last 50 years has improved to approximately 80 percent overall from 10 to 20 percent back in the old days, so there has been a dramatic improvement. But 20 percent of kids with cancer still die of their disease so progress has to continue.”
Dr Berkow pointed out that survival rates for childhood cancers increased rapidly from 1975 to 1995, but that progress then slowed. He said that barriers to progress include funding for childhood cancer research lagging far behind that for adult cancer in the United States, poor understanding in medical science of the causes of childhood cancer and the difficulty and time needed to develop new drugs, which often takes 15 years from inception to approval by the Food and Drug Administration (FDA).
The Visiting Professorship Program is a WCM-Q initiative that brings leading figures in medical education and healthcare to the college to view its state-of-the-art facilities and affiliate teaching hospitals, offer advice on career development to students and establish strong links between WCM-Q and other elite medical institutions. During his visit Dr Berkow, who is the Pediatric Residency Program director in University of South Alabama, also met with students and the clinical faculty at Hamad Medical Corporation and Sidra Medicine.
Dr Amal Khidir, associate professor of Pediatrics and director of the Pediatric Clerkship at WCM-Q said: “It is very important for their future career development that medical students are offered more opportunities to interact with well-established educators and clinicians. We were extremely privileged and pleased to be able to welcome a programme director of Dr Berkow’s calibre here to WCM-Q to not only give our students some extremely helpful advice, but also deliver an extremely enlightening and informative lecture on paediatric oncology at Grand Rounds.”
The lecture was accredited locally by the Qatar Council for Healthcare Practitioners-Accreditation Department (QCHP-AD) and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
Doha
TREATMENT of childhood cancer has been dramatically improved by advances in drug therapies over the years, an expert on paediatric oncology has said. He was explaining developments in childhood cancer care over the past several decades at Weill Cornell Medicine-Qatar’s (WCM-Q) Grand Rounds.
Dr Roger L Berkow, professor and vice chair of Pediatrics at the University of South Alabama (USA), also discussed the challenges to further progress.
Dr Berkow, who gave the lecture during a visit to WCM-Q as part of the college’s Visiting Professorship Program (VPP), said: “The cure rate over the last 50 years has improved to approximately 80 percent overall from 10 to 20 percent back in the old days, so there has been a dramatic improvement. But 20 percent of kids with cancer still die of their disease so progress has to continue.”
Dr Berkow pointed out that survival rates for childhood cancers increased rapidly from 1975 to 1995, but that progress then slowed. He said that barriers to progress include funding for childhood cancer research lagging far behind that for adult cancer in the United States, poor understanding in medical science of the causes of childhood cancer and the difficulty and time needed to develop new drugs, which often takes 15 years from inception to approval by the Food and Drug Administration (FDA).
The Visiting Professorship Program is a WCM-Q initiative that brings leading figures in medical education and healthcare to the college to view its state-of-the-art facilities and affiliate teaching hospitals, offer advice on career development to students and establish strong links between WCM-Q and other elite medical institutions. During his visit Dr Berkow, who is the Pediatric Residency Program director in University of South Alabama, also met with students and the clinical faculty at Hamad Medical Corporation and Sidra Medicine.
Dr Amal Khidir, associate professor of Pediatrics and director of the Pediatric Clerkship at WCM-Q said: “It is very important for their future career development that medical students are offered more opportunities to interact with well-established educators and clinicians. We were extremely privileged and pleased to be able to welcome a programme director of Dr Berkow’s calibre here to WCM-Q to not only give our students some extremely helpful advice, but also deliver an extremely enlightening and informative lecture on paediatric oncology at Grand Rounds.”
The lecture was accredited locally by the Qatar Council for Healthcare Practitioners-Accreditation Department (QCHP-AD) and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
